Application of customized industry-specific metrics to assessment of capital projects performances

The pharmaceutical industry is unique in its procedures and methods of manufacture, and thus requires a distinct project management approach. With the consideration of specific facility delivery processes of the industry, assessment of pharmaceutical construction project performance is required as a first step of improving their performance. To do so, industry-specific metrics tuned to the characteristics of the industry are developed, followed by establishment of a hierarchical structure enabling pharmaceutical projects to be properly grouped for performance assessment. Using collected data for producing metric values, descriptive and statistical analyses are performed to assess pharmaceutical project cost, schedule, and dimensional performances by three major types: bulk manufacturing, secondary manufacturing, and laboratory. By utilizing these industry-specific metrics and analyses results, the industry can find solutions to more effectively manage cost, schedule, and other resources for the delivery of pharmaceutical construction projects.